Publicaciones en colaboración con investigadores/as de Centro Nacional de Microbiología (10)

2024

  1. Evolution of invasive pneumococcal disease by serotype 3 in adults: a Spanish three-decade retrospective study

    The Lancet Regional Health - Europe, Vol. 41

2023

  1. Enhancing SARS-CoV-2 Surveillance through Regular Genomic Sequencing in Spain: The RELECOV Network

    International Journal of Molecular Sciences, Vol. 24, Núm. 10

2022

  1. Genomic features of predominant non-PCV13 serotypes responsible for adult invasive pneumococcal disease in Spain

    The Journal of antimicrobial chemotherapy, Vol. 77, Núm. 9, pp. 2389-2398

2021

  1. Azole resistance survey on clinical Aspergillus fumigatus isolates in Spain

    Clinical Microbiology and Infection, Vol. 27, Núm. 8, pp. 1170.e1-1170.e7

2020

  1. Emerging non-13-valent pneumococcal conjugate vaccine (PCV13) serotypes causing adult invasive pneumococcal disease in the late-PCV13 period in Spain

    Clinical Microbiology and Infection, Vol. 26, Núm. 6, pp. 753-759

2011

  1. Epidemiological and molecular aspects of rifampicin-resistant Staphylococcus aureus isolated from wounds, blood and respiratory samples

    Journal of Antimicrobial Chemotherapy, Vol. 66, Núm. 5, pp. 997-1000

2009

  1. Changes in fluoroquinolone-resistant Streptococcus pneumoniae after 7-valent conjugate vaccination, Spain

    Emerging Infectious Diseases, Vol. 15, Núm. 6, pp. 905-911

2006

  1. Molecular epidemiology and variants of the multidrug-resistant Streptococcus pneumoniae Spain14-5 international clone among Spanish clinical isolates

    Journal of Antimicrobial Chemotherapy, Vol. 57, Núm. 4, pp. 654-660

2005

  1. Clinical isolates of the Spain14-5 clone of Streptococcus pneumoniae carry a recombinant rpoB gene [3]

    Antimicrobial Agents and Chemotherapy

2004

  1. Spectrum of antibiotic resistance of the Spain14-5 Streptococcus pneumoniae clone over a 22 year period

    Journal of Antimicrobial Chemotherapy, Vol. 53, Núm. 4, pp. 620-625